Ptc Therapeutics, Inc.

Scott J Barraza

Gary Mitchell Karp

Suresh D Babu

Jana Narasimhan

Anuradha Bhattacharyya

Matthew G Woll

Anthony R Mazzotti

Zhenrong Xu

Anthony A Turpoff

Jigar S Patel

Lukiana Amedzo

Young-Choon Moon

Nanjing Zhang

Nadiya Sydorenko

Guangming Chen

Ramil Y Baiazitov

Wuming Yan

Md Rauful Alam

Andrew J Kassick

Nathaniel T Kenton

Sudipta Pal

Nicholas W Mszar

Anthony Turpoff

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

Heteroaryl compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I) or Formula (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. 

Growing community of inventors

Piscataway, NJ, United States of America

Scott J Barraza